Evidence map›Paper›PMID 39841310›Full record

ArticleMedical & biological engineering & computing2025

CTCNet: a fine-grained classification network for fluorescence images of circulating tumor cells.

Juntao Wu, Han Wang, Yuman Nie, Yaoxiong Wang, Wei He, Guoxing Wang, Zeng Li, Jiajun Chen, Wenliang Xu

Abstract read
PubMed Publisher
In one paragraph

Article in Medical & biological engineering & computing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Juntao WuSchool of Electronic and Information Engineering, Anhui Jianzhu University, Hefei, 230601, Anhui, China.
Han WangHefei Institute of Physical Sciences, Chinese Academy of Sciences, Hefei, 230031, Anhui, China.
Yuman NieHefei Institute of Physical Sciences, Chinese Academy of Sciences, Hefei, 230031, Anhui, China. nie@iim.cas.cn.ORCID http://orcid.org/0000-0003-1205-4113
Yaoxiong WangHefei Institute of Physical Sciences, Chinese Academy of Sciences, Hefei, 230031, Anhui, China.
Wei HeAnhui BioX-Vision Biological Technology Co., Ltd, Hefei, 230031, Anhui, China.
Guoxing WangAnhui BioX-Vision Biological Technology Co., Ltd, Hefei, 230031, Anhui, China.
Zeng LiSchool of Pharmacy, Anhui Medical University, Hefei, 230032, Anhui, China.
Jiajun ChenAnhui BioX-Vision Biological Technology Co., Ltd, Hefei, 230031, Anhui, China.
Wenliang XuAnhui BioX-Vision Biological Technology Co., Ltd, Hefei, 230031, Anhui, China.

Funding

Key Technology Research and Development List and Command Program of Hefei 2023SGJ035
6 · The paper itself

Abstract

The identification and categorization of circulating tumor cells (CTCs) in peripheral blood are imperative for advancing cancer diagnostics and prognostics. The intricacy of various CTCs subtypes, coupled with the difficulty in developing exhaustive datasets, has impeded progress in this specialized domain. To date, no methods have been dedicated exclusively to overcoming the classification challenges of CTCs. To address this deficit, we have developed CTCDet, a large-scale dataset meticulously annotated based on the distinctive pathological characteristics of CTCs, aimed at advancing the application of deep learning techniques in oncological research. Furthermore, we introduce CTCNet, an innovative hybrid architecture that merges the capabilities of CNNs and Transformers to achieve precise classification of CTCs. This architecture features the Parallel Token mixer, which integrates local window self-attention with large-kernel depthwise convolution, enhancing the network's ability to model intricate channel and spatial relationships. Additionally, the Deformable Large Kernel Attention (DLKAttention) module leverages deformable convolution and large-kernel operations to adeptly delineate the nuanced features of CTCs, substantially boosting classification efficacy. Comprehensive evaluations on the CTCDet dataset validate the superior performance of CTCNet, confirming its ability to outperform other general methods in accurate cell classification. Moreover, the generalizability of CTCNet has been established across various datasets, establishing its robustness and applicability. What is more, our proposed method can lead to clinical applications and provide some help in assisting cancer diagnosis and treatment. Code and Data are available at https://github.com/JasonWu404/CTCs_Classification .

Indexed as

Image Processing, Computer-AssistedNeoplastic Cells, CirculatingNeural Networks, ComputerOptical ImagingAlgorithmsDeep LearningHumansCirculating tumor cellsCNNCTCDetCTCNetTransformer

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.